Achievement of cure following allogeneic HSCT with Flu-Bu regimen in a patient with severe mycosis fungoides and Sezary Syndrome

Article Sidebar

PDF HTML
Submitted: November 24 2019
Published: Dec 6, 2019
DOI: 10.29328/journal.acr.1001025

Main Article Content

Mahmut Yeral*
Department of Adult Hematology, Baskent University, Internal Medicine, Hematology, Bone Marrow Transplantation Unit, Adana, Turkey

Article Details

Yeral, M. (2019). Achievement of cure following allogeneic HSCT with Flu-Bu regimen in a patient with severe mycosis fungoides and Sezary Syndrome. Archives of Case Reports, 3(1), 054–055. https://doi.org/10.29328/journal.acr.1001025
Letter to Editor

Copyright (c) 2019 Yeral M.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, et al. Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution. Ann Oncol. 2015; 26: 2490-2495. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26416896

Lechowicz MJ, Lazarus HM, Carreras J, Laport GG, Cutler CS, et al. Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome. Bone Marrow Transplant. 2014; 49: 1360-1365. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25068422

Şanlı H, Akay BN, Saral S, Okçu Heper A, Topçuoğlu P. Unique Presentation of Leukemic Cutaneous CD3/TCR- Phenotype T-Cell Lymphoma with Complete Remission after Allogeneic Stem Cell Transplantation. Turk J Haematol. 2017; 34: 194-195. https://www.ncbi.nlm.nih.gov/pubmed/28008858

Atilla E, Atilla PA, Bozdag SC, Yuksel MK, Toprak SK, et al. Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS). Int J Hematol. 2017; 106: 426-430. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28466385

Lechowicz MJ, Lazarus HM, Carreras J, Laport GG, Cutler CS, et al. Allogeneic hematopoietic cell transplantatıon for mycosis fungoides and sezary syndrome. Bone Marrow Transplant. 2014; 49: 1360–1365. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25068422

Soligo D, Ibatici A, Berti E, Morandi P, Longhi E, et al. Treatment of advanced mycosis fungoides by allogeneic stemcell transplantation with a nonmyeloablative regimen. Bone Marrow Transplant. 2003; 31: 663- 666. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12692606

Herbert KE1, Spencer A, Grigg A, Ryan G, McCormack C, et al. Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation. Bone Marrow Transplant. 2004; 34: 521-525. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15286686

Duarte RF, Canals C, Onida F, Gabriel IH, Arranz R, et al. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2010; 28: 4492–4499. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20697072

Yang J, Cai Y, Jiang JL, Wan LP, Yan SK, et al. Anti-thymocyte globulin could improve the outcome of allogeneic hematopoietic stem cell transplantation in patients with highly aggressive T-cell tumors. Blood Cancer J. 2015; e332.